David D Chang's Net Worth

$38.8 Million

Estimate Recalculated Jun 20, 2024 03:35PM EST

Who is David D Chang?

David D Chang has an estimated net worth of $38.8 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., and Kite Pharma, Inc..

SEC CIK

David D Chang's CIK is 0001611024

Past Insider Trading and Trends

2019 was David D Chang's most active year for acquiring shares with 16 total transactions. David D Chang's most active month to acquire stocks was the month of February. 2017 was David D Chang's most active year for disposing of shares, totalling 28 transactions. David D Chang's most active month to dispose stocks was the month of September. 2018 saw David D Chang paying a total of $720,000.00 for 69,946 shares, this is the most they've acquired in one year. In 2017 David D Chang cashed out on 670,050 shares for a total of $42,606,228.59, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allogene Therapeutics, Inc. (ALLO) Snapshot price: $4.097

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.72%
344.83K
$2.90
$1,000,001.20
4.81M
May 16
Form 4
-1.18%
-53.39K
$4.33
-$231,191.69
4.47M
Mar 14
Form 4
+7.57%
317.8K
—
—
4.51M
Jan 25
Form 4
+84.80%
1.92M
—
—
4.19M
Mar 22
Form 4
-0.97%
-22.34K
$5.56
-$124,210.40
2.27M
Mar 14
Form 4
—
0
—
—
0
Mar 23
Form 4
-1.02%
-23.65K
$7.65
-$180,878.82
2.29M
Mar 15
Form 4
+1.20%
27.41K
$18.22
$499,410.20
2.31M
May 24
Form 4/A
+31.65%
411.56K
—
—
1.71M
Aug 31
Form 4
+3.65%
80.45K
—
—
2.28M
Mar 26
Form 4
-0.92%
-20.51K
$38.57
-$791,270.51
2.2M
Mar 15
Form 4
+22.70%
874.43K
—
—
4.73M
Scheduled
Mar 18 - Apr 24
Form 4
—
0
—
—
0
Mar 18
Form 4
-0.46%
-20.34K
$19.65
-$392,615.23
4.43M
Mar 16
Form 4
+0.55%
18.79K
—
—
3.43M
Scheduled
Mar 4
Form 4
+0.55%
18.79K
—
—
3.41M
Scheduled
Nov 19
Form 4
+0.56%
18.79K
—
—
3.39M
Scheduled
Oct 25
Form 4
+0.56%
18.79K
—
—
3.37M
Scheduled
Sep 23
Form 4
+0.56%
18.79K
—
—
3.35M
Scheduled
Sep 5
Form 4
+0.57%
18.79K
—
—
3.33M
Scheduled
Jul 18
Form 4
+0.50%
16.54K
—
—
3.31M
Scheduled
Jun 18 - Jul 10
Form 4
+1.06%
11.75K
—
—
1.13M
Scheduled
May 13
Form 4
+1.07%
11.75K
—
—
1.11M
Scheduled
Apr 26
Form 4
+8.67%
173K
—
—
2.17M
Mar 13
Form 4
+2.31%
69.95K
$18.00
$720,000.00
3.1M
Oct 15
Form 3
—
0
—
—
0
No matching records found

Kite Pharma, Inc. No price found

EVP, R&D, Chief Medical Off.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-57.42K
$180.00
—
0
Sep 11 - Oct 3
Form 4
+14.05%
7.07K
$179.66
-$1,424,195.74
57.42K
Sep 25
Form 4
—
0
$44.49
-$1,503,943.80
50.16K
Scheduled
May 1
Form 4
—
0
$44.22
-$1,493,065.56
50.16K
Scheduled
Apr 3
Form 4
—
0
$43.03
-$4,336,041.00
50.16K
Scheduled
Mar 1
Form 4
+98.71%
24.8K
—
—
49.92K
Dec 22
Form 4
-6.64%
-1.79K
$50.86
-$90,937.68
25.12K
Dec 20
Form 4
+267.96%
18.5K
—
—
25.4K
Dec 17
Form 4
—
0
$43.46
-$2,252,404.00
6.9K
Scheduled
Nov 10
Form 4
—
0
$38.99
-$494,238.89
6.9K
Scheduled
Nov 2
Form 4
—
0
$31.00
-$371,294.00
6.9K
Scheduled
Oct 1
Form 4
—
0
$30.95
-$370,447.00
6.9K
Scheduled
Sep 3 - Sep 8
Form 4
—
0
$39.50
-$502,189.22
6K
Scheduled
Aug 3
Form 4
—
0
$34.41
-$423,727.56
6K
Scheduled
Jul 1
Form 4
+200.00%
4K
$33.67
-$317,695.51
6K
Scheduled
Jun 25 - Jun 15
Form 4
—
0
—
—
0
Dec 24
Form 3
—
0
—
—
0
No matching records found